CLASSIFICATION IS DETERMINED IN ACCORDANCE WITH THE FOLLOWING:
GENERAL INTERPRETATIVE RULES (GIRS)
GIR 1 HAS BEEN USED TO CLASSIFY THIS PRODUCT BY THE TERMS OF THE HEADING 3004
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (INCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS FOR RETAIL SALE
3004 AND ANY RELATIVE SECTION OR CHAPTER NOTES.
GIR 5(B) HAS BEEN USED AS THE GOODS ARE PACKED IN PACKAGING NORMALLY USED FOR SUCH GOODS.
GIR 6 HAS BEEN USED TO CLASSIFY THE GOODS TO SUBHEADING LEVEL.
CN CODE 3004320000 FOR MEDICAMENTS CONTAINING CORTICOSTEROID HORMONES, THEIR DERIVATIVES OR STRUCTURAL ANALOGUES.
ALSO CLASSIFIED IN ACCORDANCE WITH THE FOLLOWING:
SECTION VI - PRODUCTS OF THE CHEMICAL OR ALLIED INDUSTRIES (CHAPTER 28 - 38)
CHAPTER 30 - PHARMACEUTICAL PRODUCTS
CHAPTER 30 NOTE 3
HYDROCORTISONE SODIUM SUCCINATE AS THE ACTIVE INGREDIENT IS AN INN CHEMICAL OF HEADING 29372200
HARMONISED SYSTEM EXPLANATORY NOTES
(A) (B) .
.